Reduced Graphene Oxide Decorated with AuNPs as a New Aptamer-Based Biosensor for the Detection of Androgen Receptor from Prostate Cells
暂无分享,去创建一个
Bruno P. Crulhas | Caroline R. Basso | João P. R. L. L. Parra | Gustavo R. Castro | Valber A. Pedrosa | B. Crulhas | V. Pedrosa | C. R. Basso | G. R. Castro | G. Castro
[1] A. Renshaw,et al. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. , 2002, Urology.
[2] Chawnshang Chang,et al. Molecular cloning of human and rat complementary DNA encoding androgen receptors. , 1988, Science.
[3] L. Chung,et al. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. , 2005, The Journal of urology.
[4] B. Crulhas,et al. An easy way to detect dengue virus using nanoparticle-antibody conjugates. , 2018, Virology.
[5] Ji Won Suk,et al. Graphene and Graphene Oxide: Synthesis, Properties, and Applications , 2010 .
[6] Joseph Wang,et al. Point-of-care biosensor systems for cancer diagnostics/prognostics. , 2006, Biosensors & bioelectronics.
[7] Guocheng Yang,et al. Controlled electrochemical behavior of indium tin oxide electrode modified with Pd nanoparticles via electrospinning followed by calcination toward nitrite ions , 2012 .
[8] Zhanfang Ma,et al. Electrochemical immunosensor for simultaneous detection of multiplex cancer biomarkers based on graphene nanocomposites. , 2013, Biosensors & bioelectronics.
[9] Dong-Sik Shin,et al. An electrochemical aptasensor for detection of bovine interferon gamma , 2017 .
[10] Jin Zhang,et al. Electrochemical and optical biosensors for early-stage cancer diagnosis by using graphene and graphene oxide , 2017, Cancer Nanotechnology.
[11] Jorge Yao,et al. Androgen receptor is a tumor suppressor and proliferator in prostate cancer , 2008, Proceedings of the National Academy of Sciences.
[12] M. Karp,et al. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection. , 2005, Biosensors & bioelectronics.
[13] Marcos R. V. Lanza,et al. Carbon nanotubes modified with antimony nanoparticles in a paraffin composite electrode: Simultaneous determination of sulfamethoxazole and trimethoprim , 2013 .
[14] H. Cammann,et al. PSA and new biomarkers within multivariate models to improve early detection of prostate cancer. , 2007, Cancer letters.
[15] Xianbo Lu,et al. Gold Nanoparticles dotted Reduction Graphene Oxide Nanocomposite Based Electrochemical Aptasensor for Selective, Rapid, Sensitive and Congener-Specific PCB77 Detection , 2017, Scientific Reports.
[16] J. Thrasher,et al. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice. , 2012, Nanomedicine.
[17] D. Ornstein,et al. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. , 1997, JAMA.
[18] P. Schellhammer,et al. Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens , 2018, The Journal of urology.
[19] J. Trapman,et al. The androgen receptor in prostate cancer. , 1996, Pathology, research and practice.
[20] D. Rowley,et al. The reactive stroma microenvironment and prostate cancer progression. , 2012, Endocrine-related cancer.
[21] Byeong-Su Kim,et al. Transparent, flexible conducting hybrid multilayer thin films of multiwalled carbon nanotubes with graphene nanosheets. , 2010, ACS nano.
[22] C. Lawton,et al. Screening and Prostate-Cancer Mortality in a Randomized European Study , 2010 .
[23] X. Qu,et al. New Horizons for Diagnostics and Therapeutic Applications of Graphene and Graphene Oxide , 2013, Advanced materials.
[24] Andre K. Geim,et al. The rise of graphene. , 2007, Nature materials.
[25] D. Astruc,et al. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. , 2004, Chemical reviews.
[26] F. Lowe,et al. The effects of prostatic manipulation on prostate-specific antigen levels. , 1997, The Urologic clinics of North America.
[27] David J. Lee. High androgen receptor levels are predictive of decreased survival in prostate cancer. , 2003, Clinical prostate cancer.
[28] Donald P. McDonnell,et al. International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors , 2006, Pharmacological Reviews.
[29] B. Mobbs,et al. Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: can estrogen treatment increase androgen receptor content? , 1983, Journal of steroid biochemistry.
[30] N. Weigel,et al. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. , 2013, Pharmacology & therapeutics.
[31] Shaker A Mousa,et al. Biosensors: the new wave in cancer diagnosis. , 2010, Nanotechnology, science and applications.
[32] M. Marberger,et al. Association of polymorphisms within androgen receptor, 5α‐reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men , 2002, The Prostate.
[33] Jaesung Park,et al. Graphene‐Encapsulated Nanoparticle‐Based Biosensor for the Selective Detection of Cancer Biomarkers , 2011, Advanced materials.
[34] N. M. Julkapli,et al. Graphene–Gold Nanoparticles Hybrid—Synthesis, Functionalization, and Application in a Electrochemical and Surface-Enhanced Raman Scattering Biosensor , 2016, Materials.
[35] I. Cesarino,et al. Reduced graphene oxide modified with silver nanoparticles for the electrochemical detection of estriol , 2018 .
[36] Martin E. Gleave,et al. Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer , 2015, Clinical Cancer Research.
[37] I. Cesarino,et al. Electrochemical oxidation of sulfamethazine on a glassy carbon electrode modified with graphene and gold nanoparticles , 2016 .
[38] G. Coetzee,et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. , 1997, Journal of the National Cancer Institute.
[39] Wei‐De Zhang,et al. Electrochemical determination of methyl parathion at a Pd/MWCNTs-modified electrode , 2010 .
[40] S. Stankovich,et al. Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide , 2007 .
[41] B. Crulhas,et al. Electrochemical aptamer-based biosensor developed to monitor PSA and VEGF released by prostate cancer cells , 2017, Analytical and Bioanalytical Chemistry.
[42] Chunhai Fan,et al. Aptamer-based biosensors , 2008 .
[43] J. Richie,et al. COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE CANCER: RESULTS OF A MULTICENTER CLINICAL TRIAL OF 6,630 MEN , 1994, The Journal of urology.
[44] João P. R. L. L. Parra,et al. Using an Electrochemical Aptasensor to Early Detect Prostate Specific and Free Prostate Specific Antigens Released by Cancer Cells , 2018, Electroanalysis.
[45] Yang Yang,et al. Low-temperature solution processing of graphene-carbon nanotube hybrid materials for high-performance transparent conductors. , 2009, Nano letters.
[46] G. Jenster,et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. , 2017, European urology.
[47] J. Veldscholte,et al. Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids. , 1990, Biochimica et biophysica acta.
[48] I. Cesarino,et al. Determination of serotonin on platinum electrode modified with carbon nanotubes/polypyrrole/silver nanoparticles nanohybrid. , 2014, Materials science & engineering. C, Materials for biological applications.
[49] Guoliang Zhang,et al. Gold nanoparticles–graphene hybrids as active catalysts for Suzuki reaction , 2010 .
[50] I. Mowszowicz,et al. Expression of androgen receptor coactivators in normal and cancer prostate tissues and cultured cell lines , 2003, The Prostate.
[51] Chawnshang Chang,et al. Endocrine mechanisms of disease: Expression and degradation of androgen receptor: mechanism and clinical implication. , 2003, The Journal of clinical endocrinology and metabolism.
[52] K. Yong,et al. A Review on Functionalized Gold Nanoparticles for Biosensing Applications , 2011 .
[53] Chawnshang Chang,et al. Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication , 2003 .
[54] B. Crulhas,et al. Aptamer-Based Biosensor Developed to Monitor MUC1 Released by Prostate Cancer Cells , 2017 .
[55] P. Kantoff,et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[56] P. Righetti,et al. Capillary electrophoresis of polymerase chain reaction‐amplified products in polymer networks: The case of Kennedy's disease , 1994, Electrophoresis.
[57] Aicheng Chen,et al. Au nanoparticle/graphene nanocomposite as a platform for the sensitive detection of NADH in human urine. , 2015, Biosensors & bioelectronics.
[58] I. Cesarino,et al. Synthesis of Silver Nanoparticle‐Graphene Composites for Electroanalysis Applications using Chemical and Electrochemical Methods , 2017 .
[59] N. Kyprianou,et al. Androgen receptor and growth factor signaling cross-talk in prostate cancer cells. , 2008, Endocrine-related cancer.